Susquehanna Fundamental Investments’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Susquehanna Fundamental Investments’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-9,545	Closed	-$801K	–	1786
2021 Q2	$801K	Hold	9,545	–	–	0.01%	957
2021 Q1	$463K	Hold	9,545	–	–	0.01%	1166
2020 Q4	$450K	Hold	9,545	–	–	0.01%	1144
2020 Q3	$449K	Buy	+9,545	New	+$315K	0.01%	917

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Cederberg Capital London, United Kingdom $186M AUM 21.27% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ZAM

Zeal Asset Management Central, Hong Kong $39.4M AUM 38.83% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Susquehanna Fundamental Investments's NBP Position: Q3 2021 in Review

Susquehanna Fundamental Investments sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q3 2021, closing a stake of 9,545 shares — an estimated $801K sold.

Susquehanna Fundamental Investments first reported a position in NBP in Q3 2020 and held it in 4 quarters. The position peaked at $801K in Q2 2021. 144 funds tracked by Wall St. Rank hold NBP as of Q3 2021.

Susquehanna Fundamental Investments reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q3 2021 after selling out during the quarter.
Susquehanna Fundamental Investments sold 9,545 NovaBridge Biosciences American Depositary Shares shares in Q3 2021, an estimated $801K.
Susquehanna Fundamental Investments first reported a position in NovaBridge Biosciences American Depositary Shares in Q3 2020 and held it in 4 quarters.
Susquehanna Fundamental Investments's NovaBridge Biosciences American Depositary Shares position peaked at $801K in Q2 2021.
144 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q3 2021.

Based on Susquehanna Fundamental Investments's 13F filing for Q3 2021, filed 15 Nov 2021.